Evidence map›Paper›PMID 33854337›Full record

ArticleOncoTargets and therapy2021

Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline

Yang Jiao, Chen Fang, Yuchen Yang, Lin Shao, Yi Huang, Qinying Sun, Yuchao Dong

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yang Jiao *Pulmonary and Critical Care Medicine, Changhai Hospital, The Naval Medical University, Guangzhou, People's Republic of China.ORCID 0000-0002-9904-4227
Chen Fang *Pulmonary and Critical Care Medicine, Changhai Hospital, The Naval Medical University, Guangzhou, People's Republic of China.
Yuchen YangBurning Rock Biotech, Guangzhou, People's Republic of China.
Lin ShaoBurning Rock Biotech, Guangzhou, People's Republic of China.
Yi HuangPulmonary and Critical Care Medicine, Changhai Hospital, The Naval Medical University, Guangzhou, People's Republic of China.
Qinying SunPulmonary and Critical Care Medicine, Changhai Hospital, The Naval Medical University, Guangzhou, People's Republic of China.
Yuchao DongPulmonary and Critical Care Medicine, Changhai Hospital, The Naval Medical University, Guangzhou, People's Republic of China.ORCID 0000-0002-1910-792X
Second Military Medical University · CNBurning Rock Biotech (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

lung adenosquamous carcinomaMET exon 14 skipping mutationnext-generation sequencingNGSrapid disease progressionrare germline mutation

Identifiers

PMID33854337
PMCPMC8039198
OpenAlexW3150123753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.